Breaking News

ICON CEO Elected to ACRO Chair

By Kristin Brooks | January 14, 2014

Murray to promote the industry, Cunningham to serve second term as secretary

Ciaran Murray, chief executive officer of ICON plc, has been elected 2014 chairman of the Association of Clinical Research Organizations (ACRO). Additionally, ICON legal counsel, Diarmaid Cunningham, has been elected to serve as secretary of ACRO for a second term.
 
ACRO, founded in 2002, is dedicated promoting public understanding of clinical research and highlighting CRO expertise across clinical research. ACRO represents the CRO industry globally to pharma, biopharma, and medical device companies, as well as regulators, peer associations, academic organizations, patient groups, the media, and the public.
 
“I am honored to lead ACRO at this time when clinical research organizations are increasingly being recognized for the innovation and expertise we bring to the drug development process,” said Mr. Murray. “I look forward to continuing the work that ACRO has done in promoting our industry as one that conducts safe, ethical and high-quality clinical research to deliver medicines that benefit patients worldwide.”

blog comments powered by Disqus
  • Cold Chain Packaging Trends

    Cold Chain Packaging Trends

    Kristin Brooks, Contract Pharma||February 4, 2016
    Susan Li of UPS discusses supply chain trends, challenges, and packaging innovations

  • Packaging Equipment Trends Preview

    Packaging Equipment Trends Preview

    Kristin Brooks, Contract Pharma||January 26, 2016
    Christian Treitel of Bosch Packaging Technology discusses trends and capabilities

  • Tackling Drug Serialization Challenges

    Tackling Drug Serialization Challenges

    Tim Wright, editor||January 22, 2016
    Siemens and Adents together will develop a combined hardware plus software solution for pharma industry

  • Elemental Impurity Testing

    Elemental Impurity Testing

    Dr. Andrew Fussell, PANalytical ||January 28, 2016
    Advances in elemental impurity testing aid compliance with new USP requirements

  • Fit-For-Purpose Assay Development in Bioanalysis

    Fit-For-Purpose Assay Development in Bioanalysis

    Franklin Spriggs, Ligand Binding Assay Group Leader; Ashley Brant, Program Manager, AIT Bioscience||January 28, 2016
    The success of bioanalytical studies relies on the selection of the most suitable analytical method but the timeline of method development and types of analyses involved vary greatly.

  • Optimizing Collaboration Effectiveness in Alliance Partnerships

    Optimizing Collaboration Effectiveness in Alliance Partnerships

    Mary Jo Lamberti, Phil Birch, Ranjana Chakravarthy, Ken Getz, Tufts CSDD||January 28, 2016